Member
8 Awards

The Geneva Foundation


The Geneva Foundation is a 501(c)3 nonprofit established in 1993, dedicated to advancing military medicine through research, development, and education. With a commitment to ensuring optimal health for service members and the communities they serve, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes.

Industries

clinical-trials
education
non-profit

Nr. of Employees

large (251-1000)

The Geneva Foundation

Awards

Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)

UCM-CARE: Universal Combat Matrix for Comprehensive and Rapid Hemostatic Efficacy in Battlefield Wound Care

Funding (ceiling)

$2,026,395.55

Award Year

2024

Military Operational Medicine (MOM) - Improving Protection through Metrics for Exposure to Blast, and Enhancing Cognitive Health, Performance and Psychological Health

Development of survivability criteria and vital organ injury metrics for the whole body when exposed to extreme blast

Funding (ceiling)

$4,065,857.97

Award Year

2020

A Smart Orthopedic Knee Rehabilitation Device to Quantify and Deliver Continuity in Physical Therapy

Funding (ceiling)

$2,677,549.99

Award Year

2023

Solutions to Accelerate Return-to-Readiness following Musculoskeletal Injuries

Objective dynamic and 3D knee assessment medical device to improve recovery and accelerate return to readiness of members with knee pain

Funding (ceiling)

$716,669.39

Award Year

2023

Military Prototype Advancement Initiative (MPAI)

Identification of Risk Factors that Prevent Return to Duty and Predict Residual Disability after Knee ACL Reconstruction at Short and Long-Term Follow-up

Funding (ceiling)

$2,882,674

Award Year

2023

Development of a fieldable direct osmotherapy device for the point-of-injury reduction of cerebral edema following penetrating traumatic brain injury

Funding (ceiling)

$1,327,339

Award Year

2022

Disaster Telemedicine Response System (DISTRESS)

Funding (ceiling)

$15,983,581.37

Award Year

2020

Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)

A Comprehensive DoDTR-Compliant Database of War-Related Injuries in Ukraine: Implications for Medical Support of Large-Scale Combat Operations with Near-Peer Adversaries

Funding (ceiling)

$4,587,638.53

Award Year

2024


Products

Bioprinting and biofabrication center (research program and facility)

A research and training center focused on bioprinting, biofabrication, biomanufacturing, and point‑of‑care biotechnology development and translation.

On‑demand blood product development program

Program to develop methods and infrastructure for producing transfusion‑ready red blood cells and related products onsite to enable transfusion in austere environments.

Tele‑critical care network implementation and support

Implementation and operational support for networked tele‑critical care services to extend expert critical care guidance to bedside providers using networked mobile devices.

Clinical studies of AI‑enabled handheld ultrasound

Clinical acquisition and algorithm development program for handheld ultrasound imaging with real‑time machine learning analysis to support rapid triage of lung and trauma injuries.

Smartphone‑based mental health application (multimedia coping and self‑help tools)

A multimedia mobile application delivering personalized coping tools, distraction and relaxation exercises, activity planning, inspirational content, and support contact management; developed and evaluated in partnership with military and veterans' health organizations and assessed in clinical trials.

Expertise Areas

  • Clinical trial management
  • Biotechnology and biomanufacturing
  • Vaccine and antibody therapeutics
  • Infectious disease research
  • Show More (9)

Key Technologies

  • 3D bioprinting and biofabrication
  • Bioreactors and tissue culture systems
  • Functional near‑infrared spectroscopy (fNIRS)
  • Electroencephalography (EEG)
  • Show More (8)

Key People

President & Chief Executive Officer

LinkedIn

Kent Kester, MD COL (Ret.) USA

Chair, Board of Directors

LinkedIn

Stuart Tyner, PhD, COL (Ret.) USA

Chair, Scientific Advisory Board

LinkedIn

Matt Rueckert, MA, MBA

Chief Operating Officer

LinkedIn

Featured In Technology Showcase

Universal Combat Matrix®: Integrated Point-of-Injury Hemorrhage Control and Wound Care for the Modern Battlefield

SiOxMed’s Universal Combat Matrix® (UCM®), supported by Genevoa Foundation and MTEC under U.S. DoD Award 24-01-MPAI-032, is a point-of-injury hemostatic and regenerative platform designed to rapidly control severe bleeding and improve survival in austere and battlefield environments.


News & Updates

In 2023, Geneva marks its 30th anniversary, reflecting on its impact in advancing military medicine.

The ASTMH Annual Meeting is the premier international forum for the exchange of scientific and clinical advances in tropical medicine, hygiene and global health.

An article highlighting the contributions of Margaret Hollander in light therapy research.

Recognition of Allison Edinger for her contributions to Geneva's mission.

An article discussing Geneva's collaboration with NCI on pancreatic cancer research.

The Geneva Foundation received $5 million to support a study on sleep quality and combat sleep disorders in service members and veterans.

View All News

Capabilities


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.